CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Employee Stock Option (right to buy) | −386 | 4,947 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +20,000 | $74.42 | $1.5M | 20,000 |
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,736 | 347 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,779 | 0 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,000 | 0 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −1,166 | 0 | ||
| 2014-02-12 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −4,584 | 10,560 | ||
| 2014-02-12 | HIGGINS JOHN L President & CEO | Exercise or conversion | +16,875 | $9.96 | $168K | 127,974 |
| 2014-02-12 | HIGGINS JOHN L President & CEO | Sale | −16,875 | $75.00 | $1.3M | 111,099 |
| 2014-02-12 | HIGGINS JOHN L President & CEO | Grant or award | +8,000 | 119,099 | ||
| 2014-02-12 | HIGGINS JOHN L President & CEO | Grant or award · Employee Stock Option (right to buy) | +75,000 | $74.42 | $5.6M | 75,000 |
| 2014-02-12 | HIGGINS JOHN L President & CEO | Grant or award · Employee Stock Option (right to buy) | +10,000 | $74.42 | $744K | 85,000 |
| 2014-02-12 | HIGGINS JOHN L President & CEO | Grant or award · Employee Stock Option (right to buy) | +10,000 | $74.42 | $744K | 95,000 |
| 2014-02-12 | HIGGINS JOHN L President & CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −16,875 | 48,125 | ||
| 2014-02-12 | FOEHR MATTHEW W EVP and COO | Grant or award | +5,000 | 50,013 | ||
| 2014-02-12 | FOEHR MATTHEW W EVP and COO | Grant or award · Employee Stock Option (right to buy) | +45,000 | $74.42 | $3.3M | 45,000 |
| 2014-02-12 | FOEHR MATTHEW W EVP and COO | Grant or award · Employee Stock Option (right to buy) | +10,000 | $74.42 | $744K | 55,000 |
| 2014-02-12 | FOEHR MATTHEW W EVP and COO | Grant or award · Employee Stock Option (right to buy) | +10,000 | $74.42 | $744K | 65,000 |
| 2014-02-12 | DeSilva Nishan M VP, Corporate Development | Grant or award | +3,000 | 18,659 | ||
| 2014-02-12 | DeSilva Nishan M VP, Corporate Development | Grant or award · Employee Stock Option (right to buy) | +35,000 | $74.42 | $2.6M | 35,000 |
Page 79 of 86 · 1,712 trades